Clinical Trials
32 trialsA Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
National Institutes of Health Clinical Center (CC)
Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
Cedars-Sinai Medical Center
Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)
Massachusetts General Hospital
Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
Massachusetts General Hospital
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
National Institutes of Health Clinical Center (CC)
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
Massachusetts General Hospital
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
Massachusetts General Hospital
iCanCope With NF: Innovating an Efficacious Digital Self-management and Transitional Care Program for Adolescents With Neurofibromatosis
The Hospital for Sick Children
Neurobiology and Treatment of Reading Disability in NF-1
Vanderbilt University
Innovation in the Treatment of Persistent Pain in Adults With NF1: Implementation of the iCanCope Mobile Application- Clinical Trial
Yale University
Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1
Murdoch Childrens Research Institute
Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials
National Institutes of Health Clinical Center (CC)
OPTIMAL-SSI
Virginia Commonwealth University
COGTRAIN
Children's National Research Institute
Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1
University of Manchester
Open Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1
University of Wisconsin, Milwaukee
Pilot Randomized Control Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1
University of Wisconsin, Milwaukee
ASD/NF1inhib
University of Coimbra
Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With NF1
Shriners Hospitals for Children
A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)
NYU Langone Health
Whole-body Vibration in Children With Neurofibromatosis Type 1
Manchester University NHS Foundation Trust
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
Children's National Research Institute
Feasibility and Clinically Application of Magnetic Resonance Fingerprinting
Case Comprehensive Cancer Center
Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation
University of Aarhus
Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
Washington University School of Medicine
tDCS is NF1
University of Manchester
Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) Children
University Hospital, Toulouse
NF1-QDV
Nantes University Hospital
Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
Massachusetts General Hospital
Functional Imaging and Reading Deficit in Children With NF1
University Hospital, Toulouse
Reading Disability in Children With NF1
University Hospital, Toulouse
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Children's Hospital of Philadelphia